PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2104569
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2104569
Bacteriological Testing market size was valued at US$ 25,601.3 Million in 2025, expanding at a CAGR of 7.7% from 2026 to 2033.
Bacteriological testing has been done in order to lower the chances of being infected due to bacteria and also improve the quality and safety of the product. This kind of testing is an important part that has been emerging in connection with the requirement to conduct this kind of test in order to ensure the safety of the product. Testing for bacteriological tests is being conducted in various areas, ranging from cosmetics to food & beverages, in order to maintain the quality of the products and prevent any kind of bacterial infections. Thus, rising bacterial contamination concerns are driving increased adoption of bacteriological testing across multiple industries.
Bacteriological Testing Market- Market Dynamics
Expansion of Food Safety Regulations Driving Market Growth
Expansion of food safety regulations will be a key driving force for the bacteriological testing market, where increased levels of regulations will increase the need for advanced testing solutions for quality testing, contamination detection, and consumer protection. For example, in 2026, per the UK Food Standards Agency (FSA), the Future Food Regulation Program will improve food safety and quality controls such as food registration, the Food and Animal Health Act (FAAH), national oversight, the food hygiene rating system (FHRS), and food safety and regulatory guidelines. At the same time, they are conducting a 12-month-long public consultation on the food regulations of England, Wales, and Northern Ireland using the participation of more than 100 food industry stakeholders. These regulatory advancements are expected to accelerate adoption of advanced bacteriological testing solutions globally.
The Global Bacteriological Testing market is segmented on the basis of Bacteria, Technology, End Use, Component, Mode of Use, and Region.
Under technology, PCR holds a prominent share because of the efficiency and speed at which it detects bacterial pathogens. This results in a reduction in diagnosis time for the patients and increased efficiency in conducting tests in bacteriology testing. In April 2026, Thermo Fisher Science launched a new product known as the Applied Biosystems PowerFlex Thermal Cycler that will be able to increase the performance of amplification and increase the efficiency and workflow flexibility of their customers using molecular testing, including bacteriological and microbiological testing. The uptake of PCR is increasing owing to advancements in efficiency, speed, and pathogen detection in bacteriology testing.
Reagents & consumables have a significant share because their usage is required in all bacteriology testing, providing the most accurate way of detecting the pathogens and keeping the sample consistency and test stability. For instance, according to the U.S. Commercial Service's China Healthcare Country Commercial Guide (Trade Gov), the healthcare market of China was estimated to be over USD 1,000,000 million and is projected to surpass USD 1,500,000 million by 2029, indicating that there will be a great demand for the diagnostics and laboratory consumables needed for such testing. The devices and consumables used for diagnostics comprised about 50% of the total U.S. medical device exports to China, Thus, an increasing need for healthcare services and diagnostics has led to the increased demand for reagents and consumables.
Bacteriological Testing Market- Geographical Insights
North America holds notable share in the Bacteriological Testing market due to an already existing and well-established infrastructure of healthcare and the extensive usage of new diagnostic techniques. For example, in Feb 2025, research conducted by NIH.gov showed that new diagnostic technologies have become widely used because novel imaging and artificial intelligence technologies are applied, such as cone-beam computed tomography (CBCT), intraoral scanners, and optical coherence tomography (OCT) used in 3D imaging. At that, the disease detection in patients can be improved significantly due to increased accuracy and decreased utilization of invasive procedures. These advancements reinforce North America's leadership in bacteriological testing through innovation-driven diagnostic capabilities and healthcare modernization.
Bacteriological Testing market growing competition and increasing demand for improved microbiological testing services, operational efficiencies, and speedy testing are contributing to high competitive growth in the bacteriological testing market. The firms involved in this industry include Vimta Labs, Bureau Veritas, Intertek Group plc, and Charm Sciences, Inc. And Eurofins Scientific, among others. These firms have been making efforts towards the diversification of their services, innovation, and partnerships. In November 2025, Bureau Veritas increased its testing labs through the acquisition of Lab System Institute of Research and Testing in Brazil. Through this move, the company has diversified its testing services into food safety and packaging testing besides other bacteriological and microbiological testing services that the company already offers. These strategic initiatives are accelerating innovation, enhancing testing capabilities, and strengthening competitive positioning across the market.
In April 2026, Merck KGaA made the acquisition of JSR Life Sciences' Chromatography Business to complement its offering in downstream bioprocessing through advanced Protein A chromatography solutions used for laboratory testing of microbes and biological molecules.
In January 2025, Neogen launched MDA2QSAL96, which is known as the Molecular Detection Assay 2 - Quantitative Salmonella, used to detect Salmonella in a rapid manner. This is done to improve the bacteriological testing process.